Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis

References

• Agrawal, A. K., Agrawal, A., Pal, A., Guru, P. Y., Gupta, C. M. (2002). Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters. J Drug Target 10:41–45.
   PubMed Web of Science ®Google Scholar
• Ahmad, I., Sarkar, A. K., Bachhawat, B. K. (1989). Design of liposomes to improve delivery of amphotericin-B in the treatment of aspergillosis. Mol Cell Biochem 91(1–2):85–90.
   PubMed Web of Science ®Google Scholar
• Basu, M. K. (2005). Liposomal delivery of antileishmanial agents. J Appl Res 5:221–236.
   Google Scholar
• Carnpanero, M. A., Espuelas, M. S., Azanza, J. R., Irache, J. M. (2000). Rapid determination of intramacrophagic Amphotericin B by direct injection HPLC. Chromatographia 52:827–830.
   Web of Science ®Google Scholar
• Chatterjee, C. (1985). Human Physiology, 11th ed. (vol. 1, p. 174). Calcutta, India: Medical Allied Agency.
   Google Scholar
• Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., et al. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine 21:883–890.
   PubMed Web of Science ®Google Scholar
• Croft, S. L., Davidson, R. N., Thornton, E. A. (1991). Liposomal amphotericin B in the treatment of visceral leishmaniasis. Antimicrob Chemother 28:111–118.
   Google Scholar
• Das, N., Mahato, S. B., Naskar, K., Ghosh, D. K., Basu, M. K. (1990). Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis. Biochem Med Metab Biol 43:133–139.
   PubMedGoogle Scholar
• Davidson, R. N. (1998). Practical guide for the treatment of leishmaniasis. Drugs 56:1009–1018.
   PubMed Web of Science ®Google Scholar
• Dey, T., Anam, K., Afrin, F., Ali, N. (2000). Antileishmanial activities of stearylamine-bearing liposomes. Antimicrob Agents Chemother 44:1739–1742.
   PubMed Web of Science ®Google Scholar
• Fry, D. W., White, J. C., Goldman, I. D. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 90:809–815.
   PubMed Web of Science ®Google Scholar
• Gallis, H. A., Drew, R. H., Picard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12:308–329.
   PubMedGoogle Scholar
• Garnett, M. C. (2001). Targeted drug conjugates: principles and progress. Adv Drug Deliv Rev. 53:171–216.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., Bachhawat, B. K. (1980). Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I-labelled gamma-globulin encapsulated in liposomes. Biochim Biophys Acta 632:562–572.
   PubMed Web of Science ®Google Scholar
• Gupta, P. K., Huang, C. T. (1989). Albumin microspheres I: physicochemical characteristics. J Microencapsul 6:427–462.
   PubMed Web of Science ®Google Scholar
• Guru, P. Y., Agarwal, A. K., Singha, U. K., Singhal, A., Gupta, C. M. (1989). Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles. FEBS Lett 245:204–208.
   PubMed Web of Science ®Google Scholar
• Higuchi, Y., Kawakami, S., Oka, M., Yabe, Y., Yamashita, F., Hashida, M. (2006). Intravenous administration of mannosylated cationic liposome/NFjB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model. FEBS Lett 580:3706–3714.
   PubMed Web of Science ®Google Scholar
• Kumar, P.V., Asthana, A., Dutta, T., Jain, N. K. (2006). Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 14(8): 1–11.
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein, G., Mehta, R., Hopfer, R. L., Mills, K., Kasi, L., Mehta, K., et al. (1983). Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated Amphotericin B. Disease 147:939–945.
   Google Scholar
• Manosroi, A., Kongkaneramit, L., Manosroi, J. (2004). Stability and transdermal absorption of topical amphotericin B liposome formulations. Int J Pharm 270:279–286.
   PubMed Web of Science ®Google Scholar
• Mitra, M., Mandal, A. K., Chatterjee, T. K., Das, N. (2005). Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral Leishmaniasis. J Drug Targ 13:285–293.
   PubMed Web of Science ®Google Scholar
• Nimje, N., Agarwal, A., Saraogi, G. K., Lariya, N., Rai, G., Agrawal, H., et al. (2009). Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Targ 17:777–787.
   PubMed Web of Science ®Google Scholar
• Paradisi, A., Capizzi, R., Zampetti, A., Proietti, I., De Simone, C., Feliciani, C., et al. (2005). Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B. J Infect 51:e261–e264
   PubMed Web of Science ®Google Scholar
• Sharma, P., Rastogi, S., Bhatnagar, S., Srivastava, J. K., Dube, A., Guru, P. Y., et al. (2003). Antileishmanial action of a plant Tephrosia pupurea and its fractions against experimental visceral leishmaniasis. Drug Dev Res 60:285–293.
   Web of Science ®Google Scholar
• Sharma, P., Singh, N., Garg, R., Haq, W., Dube, A. (2004). Efficacy of human b-casein fragment (54–59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters. Peptides 25:1873–1881.
   PubMed Web of Science ®Google Scholar
• Sihorkar, V., Vyas, S. P. (2001). The potential of polysaccharide anchored liposomes in drug delivery and drug targeting, targeting, and immunization. J Pharm Pharmaceut Sci 4:138–158.
   PubMed Web of Science ®Google Scholar
• Singh, N., Mishra, P. K., Kapil, A., Arya, K. R., Maurya, R., Dube, A. (2005). Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis. J Ethnopharmacol 98:83–88.
   PubMed Web of Science ®Google Scholar
• Sinha, J., Mukhopadhyay, S., Das, N., Basu, M. K. (2000). Targeting of liposomal andrographolide to L. donovani–infected macrophages in vivo. Drug Deliv 7:209–213.
   PubMed Web of Science ®Google Scholar
• Tempone, A. G., Perez, D., Rath, S., Vilarinho, A. L., Mortara, R. A., Andrade, H. F. (2004). Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine. J Antimicrob Chemother 54:60–68.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P., Goldmacher, V. S., Smirnov, V. N. (1978). Comparative studies on covalent and non-covalent immobilization of protein molecules on the surface of liposomes. Biochem Biophys Res Commun 85:983–990.
   PubMed Web of Science ®Google Scholar
• Townsend, R. W., Zutshi, A., Bekersky, I. (2001). Biodistribution of 4-[(14)C]cholesterol-Ambisome following a single intravenous administration to rats. Drug Meta Dispos 29:681–685.
   PubMed Web of Science ®Google Scholar
• Van Etten, E. W. M., OtteLambillion, M., Van, V. W., TenKate, M. T., Bakker-Wouderberg, I. A. J. M. (1995). Biodistribution of liposomal amphotericin B (ambisome) and amphotericin B desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. J Antimicrob Chemother 35:509–515.
   PubMed Web of Science ®Google Scholar
• Van Etten, E. W. M., van den Heuvel-de Groot, C., Bakker-Wouderberg, I. A. J. M. (1993). Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmbiSome) and in the treatment of systemic candidosis in immunocompetent and mice. J Antimicrob Chemother 32:723–729.
   PubMed Web of Science ®Google Scholar
• Vyas, S. P. (2000). Macrophage targeting and colloidal drug carriers. In: Vyas, S. P., Dixit, V. K. (Eds.), Advances in liposomal research ( pp. 98–120). New Delhi, India: CBS.
   Google Scholar
• Vyas, S. P., Katare, Y. K., Mishra, V., Sihorkar, V. (2000). Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm 210:1–14.
   PubMed Web of Science ®Google Scholar